These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Synthesis of novel heterocyclic ring-fused 18β-glycyrrhetinic acid derivatives with antitumor and antimetastatic activity. Gao C, Dai FJ, Cui HW, Peng SH, He Y, Wang X, Yi ZF, Qiu WW. Chem Biol Drug Des; 2014 Aug 21; 84(2):223-33. PubMed ID: 24612785 [Abstract] [Full Text] [Related]
11. Synthesis and biological activity of some antitumor active derivatives from glycyrrhetinic acid. Csuk R, Schwarz S, Kluge R, Ströhl D. Eur J Med Chem; 2010 Dec 21; 45(12):5718-23. PubMed ID: 20884085 [Abstract] [Full Text] [Related]
17. Design, synthesis, modelling studies and biological evaluation of 1,3,4-oxadiazole derivatives as potent anticancer agents targeting thymidine phosphorylase enzyme. Bajaj S, Kumar MS, Tinwala H, Yc M. Bioorg Chem; 2021 Jun 21; 111():104873. PubMed ID: 33845381 [Abstract] [Full Text] [Related]
18. Synthesis and biological evaluation of furoxan-based nitric oxide-releasing derivatives of glycyrrhetinic acid as anti-hepatocellular carcinoma agents. Lai Y, Shen L, Zhang Z, Liu W, Zhang Y, Ji H, Tian J. Bioorg Med Chem Lett; 2010 Nov 15; 20(22):6416-20. PubMed ID: 20932754 [Abstract] [Full Text] [Related]